United States securities and exchange commission logo

                           August 13, 2020

       Troy E. Wilson, Ph.D., J.D.
       President and Chief Executive Officer
       Kura Oncology, Inc.
       12730 High Bluff Drive, Suite 400
       San Diego, CA 92130

                                                        Re: Kura Oncology, Inc.
Statement on Form S-3
                                                            Filed August 6,
                                                            File No. 333-241663

       Dear Dr. Wilson:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Jeffrey
Gabor at 202-551-2544 with any questions.


                           Division of Corporation Finance

                           Office of Life Sciences
       cc:                                              Charles Bair, Esq.